603669.SS
Lionco Pharmaceutical Group Co.,Ltd. [603669.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
603669.SS Stock Summary
Top 10 Correlated ETFs
603669.SS
Top 10 Correlated Stocks
603669.SS
In the News
603669.SS Financial details
Company Rating
-
Market Cap
2.78B
Income
-222.86M
Revenue
188.72M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
497
Optionable
No
Shortable
Yes
Earnings
20 Oct 2023
P/E
-20.85
Forward P/E
-
PEG
0.47
P/S
21.18
P/B
4.49
P/C
-
P/FCF
-20.36
Quick Ratio
2.99
Current Ratio
3.24
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.31
EPS next Y
-
EPS next Q
-
EPS this Y
-393.16%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-29.57%
Revenue Q/Q
-4.73%
EPS Q/Q
-42.59%
-
-
-
-
SMA20
-3.35%
SMA50
-17.52%
SMA100
-27.95%
Inst Own
-
Inst Trans
-
ROA
-12%
ROE
-21%
ROC
-0.15%
Gross Margin
40%
Oper. Margin
-114%
Profit Margin
-118%
Payout
-2%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.94-6.07
52W High
-24.67%
52W Low
+126%
RSI
53.81
Rel Volume
4
Avg Volume
7.84M
Volume
31.34M
Perf Week
1.8%
Perf Month
-6.03%
Perf Quarter
-19.86%
Perf Half Y
-11.89%
-
-
-
-
Beta
0.248383
-
-
Volatility
0.17%, 0.27%
Prev Close
5.36%
Price
4.52
Change
10.24%
Company Profile
- Volume Average 7.84M
- Market Capitalization 2.78B
- Employee 497
- CEO Ms. Ling Ping Tao
- Headquarters Shannan,CN
- IPO Date 2015-05-28
-
Website
https://www.lingkang.com.cn 
Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products. It also operates research institutes that specialize in the research of chemical drugs, natural medicines, and biological drugs. Lionco Pharmaceutical Group Co., Ltd. was founded in 2003 and is based in Shannan, China.
